FDA Announces New Cannabis Clinical Research Guidance
The FDA announced new guidance entitled Cannabis and Cannabis-Derived Compounds; Quality Considerations for Clinical Research. Those involved in the clinical research of cannabis can rely on this FDA guidance for recommended sources of cannabis for clinical research and resources.